Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

10.1002/jor.1100090504

10.1016/S0094-1298(20)31020-8

10.1016/S0301-472X(00)00482-3

10.1091/mbc.e02-02-0105

10.1186/ar130

10.1016/0014-4827(91)90401-F

Nathanson MA, 1985, Bone matrix‐directed chondrogenesis of muscle in vitro, Clin Orthop, 200, 142, 10.1097/00003086-198511000-00022

Frassoni F, 2002, Expanded mesenchymal stem cells (MSC), co‐infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis, Bone Marrow Transplant, 29, S2

Lazarus HM, 1995, Ex vivo expansion and subsequent infusion of human bone marrow‐derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use, Bone Marrow Transplant, 16, 557

10.1359/jbmr.1999.14.7.1115

10.1182/blood.V98.8.2396

10.1016/S0301-472X(02)00820-2

in 't Anker PS, 2003, Mesenchymal stem cells in human second‐trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential, Haematologica, 88, 845

10.1016/S0301-472X(02)00967-0

10.1016/S0022-2143(03)00022-2

10.1046/j.1365-2141.2000.01986.x

Mareschi K, 2001, Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood, Haematologica, 86, 1099

10.1046/j.1365-2141.2003.04284.x

10.1182/blood-2003-04-1291

10.1093/oxfordjournals.bmb.a071847

Priest RE, 1978, Origin of cells in human amniotic fluid cultures: ultrastructural features, Lab Invest, 39, 106

10.1111/j.1348-0421.2003.tb02793.x

10.1359/jbmr.2002.17.3.394

10.1111/j.1744-313X.1991.tb00005.x

10.1200/JCO.2000.18.2.307